Simultaneous Durvalumab and Platinum-Based Chemoradiotherapy in Unresectable Stage III Non-Small Cell Lung Cancer: The Phase III PACIFIC-2 Study.

Journal:

Journal of Clinical Oncology

Published:

2025-10-14

DOI:

10.1200/jco-25-00036

Affiliations:

16

Authors:

102

Go to article

Institutions	Authors	Share
AstraZeneca Gaithersburg, MD, United States of America (USA)	2.000000	0.13
Hospital São Lucas da PUCRS, Brazil	1.000000	0.07
Centrum Onkologii, Poland	1.000000	0.07
National Korányi Institute for Pulmonology, Hungary	1.000000	0.07
Istanbul University Cerrahpaşa (IUC), Turkey	1.000000	0.07
AstraZeneca Poland, Poland	1.000000	0.07
University of Pennsylvania (Penn), United States of America (USA)	1.000000	0.07
King Chulalongkorn Memorial Hospital, Thailand	1.000000	0.07
Chungbuk National University Hospital, South Korea	1.000000	0.07
Hospital Nossa Senhora da Conceição, Brazil	1.000000	0.07
AstraZeneca United States, United States of America (USA)	1.000000	0.07
Ankara University, Turkey	1.000000	0.07
Sendai Kousei Hospital, Japan	1.000000	0.07
Charles University (CU), Czech Republic	0.500000	0.03
General University Hospital in Prague, Czech Republic	0.500000	0.03

Interested in Oncology and Carcinogenesis?